Please assess the completion status of the following clinical trial:

Trial Title: Non-Invasive Vagal Nerve Stimulation in Opioid Use Disorders

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Inclusion Criteria:~Subjects aged 18 and over who meet criteria for OUDs based on the Structured Clinical Interview for DSM-5 (SCID) interview and are stable on medication treatment.~Exclusion Criteria:~1. Positive pregnancy test~2. Meningitis~3. Traumatic brain injury~4. Neurological disorder or organic mental disorder~5. History of loss of consciousness greater than one minute~6. Current pregnancy or breastfeeding for women~7. Current or lifetime history of schizophrenia, schizoaffective disorder, or bulimia, based on the SCID~8. A history of serious medical or neurological illness, such as cardiovascular, gastrointestinal, hepatic, renal, neurologic or other systemic illness~9. Evidence of a major medical or neurological illness that is based on the clinical judgment of the study psychiatrist~10. Active implantable device (i.e. pacemaker)~11. Carotid atherosclerosis~12. Cervical vagotomy

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Active non-invasive Vagal nerve stimulation (VNS) (Type: EXPERIMENTAL): Active non-invasive Vagal Nerve Stimulation (nVNS) with opioid cues.
- Sham stimulation (Type: SHAM_COMPARATOR): Sham stimulation of vagus with opioid cues

Based on this trial design, predict the completion outcome and termination type (if applicable).